How many 8-K filings has Apogee Therapeutics, Inc. filed?

Apogee Therapeutics, Inc. (APGE) has 21 8-K (Current Event Report) filings on record, spanning Mar 2024 to May 2026.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Apogee Therapeutics, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Apogee Therapeutics, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Apogee Therapeutics, Inc. (APGE) — 8-K Filings

All 8-K filings from Apogee Therapeutics, Inc.. Browse 21 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (21)

8-K Filing — May 11, 2026
8-K Filing — Apr 24, 2026
Apogee Therapeutics Files 8-K on Material Definitive Agreement — Mar 25, 2026
Apogee Therapeutics, Inc. filed an 8-K on March 25, 2026, to report an "Entry into a Material Definitive Agreement" under Item 1.01, with the period of report b
Apogee Therapeutics Files 8-K for Material Definitive Agreement — Oct 10, 2025 Risk: medium
On October 8, 2025, Apogee Therapeutics, Inc. entered into a material definitive agreement. The company, headquartered in Waltham, MA, is involved in the biolog
Apogee Therapeutics Files 8-K — Jul 7, 2025 Risk: low
On July 7, 2025, Apogee Therapeutics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements, with no specific material e
Apogee Therapeutics Files 8-K on Shareholder Vote Matters — Jun 23, 2025 Risk: low
Apogee Therapeutics, Inc. filed an 8-K on June 23, 2025, reporting on matters submitted to a vote of security holders as of June 17, 2025. The company, incorpor
Apogee Therapeutics Files 8-K on Financials and Operations — May 12, 2025 Risk: low
On May 12, 2025, Apogee Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along
Apogee Therapeutics Enters Material Definitive Agreement — Mar 11, 2025 Risk: medium
On March 10, 2025, Apogee Therapeutics, Inc. entered into a material definitive agreement. The filing does not disclose specific details of the agreement, such
Apogee Therapeutics Files 8-K: Operations & Financials — Mar 3, 2025 Risk: low
On March 3, 2025, Apogee Therapeutics, Inc. filed an 8-K report detailing its results of operations and financial condition. The filing also included Regulation
Apogee Therapeutics Files 8-K — Feb 3, 2025 Risk: low
On February 3, 2025, Apogee Therapeutics, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, and other events, indicatin
Apogee Therapeutics Files 8-K Corporate Update — Dec 10, 2024 Risk: low
On December 10, 2024, Apogee Therapeutics, Inc. filed an 8-K report detailing a corporate update. The company, located at 221 Crescent Street, Waltham, MA, 0245
Apogee Therapeutics Files 8-K Report — Dec 2, 2024 Risk: low
On December 2, 2024, Apogee Therapeutics, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and
Apogee Therapeutics Files 8-K on Financials — Nov 12, 2024 Risk: low
Apogee Therapeutics, Inc. filed an 8-K on November 12, 2024, to report on its results of operations and financial condition. The filing includes financial state
Apogee Therapeutics Files 8-K — Oct 24, 2024 Risk: low
On October 24, 2024, Apogee Therapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. N
Apogee Therapeutics Files 8-K Report — Aug 19, 2024 Risk: low
On August 19, 2024, Apogee Therapeutics, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and
Apogee Therapeutics Files 8-K on Operations and Events — Aug 12, 2024 Risk: low
On August 12, 2024, Apogee Therapeutics, Inc. filed an 8-K report detailing significant corporate events. The filing includes information on the company's resul
Apogee Therapeutics Files 8-K on Shareholder Vote Matters — Jun 7, 2024 Risk: low
Apogee Therapeutics, Inc. filed an 8-K on June 7, 2024, reporting on a submission of matters to a vote of security holders that occurred on June 5, 2024. The co
Apogee Therapeutics Files 8-K — May 15, 2024 Risk: low
On May 15, 2024, Apogee Therapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No
Apogee Therapeutics Files 8-K for Operations and Financials — May 13, 2024 Risk: low
Apogee Therapeutics, Inc. filed an 8-K on May 13, 2024, to report on its results of operations and financial condition, as well as to file financial statements
Apogee Therapeutics Files 8-K — Mar 25, 2024 Risk: low
On March 25, 2024, Apogee Therapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits.
Apogee Therapeutics Files 8-K for Financials and Exhibits — Mar 5, 2024 Risk: low
On March 5, 2024, Apogee Therapeutics, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating routine corporate d

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX